| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |